Hematopoietic Neoplasm/Lymphoma - Hodgkin Lymphoma
NCT02166463
Clinical Trial Information
Trial Number: NCT02166463 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Lymphoma - Hodgkin Lymphoma
Trial Title:
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35, IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Study ID:
AHOD1331
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT02166463-D1 | NCT02166463-D1: There is 1 dataset associated with the PMID 36322844: NCT02166463-D1. This dataset, NCT02166463-D1, provides the information for baseline characteristics and all analyses reported in the manuscript (Tables 1-2, Figures 1-3; Supplementary Appendix tables S1, 2b, S3-6 and Figures S1-S3). There is one row per patient. |
NCT01026220
Clinical Trial Information
Trial Number: NCT01026220 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Lymphoma - Hodgkin Lymphoma
Trial Title:
A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed High Risk Hodgkin Lymphoma
Study ID:
AHOD0831
Images are available?:
Yes
Imaging data can be requested via the NCTN/NCORP Data Archive. To view imaging data details before requesting data here, visit:
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01026220-D1 | NCT01026220-D1 Dataset contains all the data which provides all the numbers, statistics, figures and tables in this publication. The data includes patient demographics, clinical characteristics and survival endpoints. This dataset is presented at patient level and includes one record per patient. |
NCT00025259
Clinical Trial Information
Trial Number: NCT00025259 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Lymphoma - Hodgkin Lymphoma
Trial Title:
A Phase III Groupwide Study of Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents With Newly Diagnosed Intermediate Risk Hodgkin Disease
Study ID:
AHOD0031
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
NCT00302003
Clinical Trial Information
Trial Number: NCT00302003 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Lymphoma - Hodgkin Lymphoma
Trial Title:
A Phase III Study for the Treatment of Children and Adolescents With Newly Diagnosed Low Risk Hodgkin Disease
Study ID:
AHOD0431
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00302003-D2 | There are two datasets associated with PMID 29738613: NCT00302003-D1 and NCT00302003-D2. This dataset, NCT00302003-D2, contains data for the toxicity section of the publication. Multiple records per patient are presented in this dataset. |
| NCT00302003-D1 | There are two datasets associated with PMID 29738613: NCT00302003-D1 and NCT00302003-D2. This dataset, NCT00302003-D1, contains all the data except for toxicities. Specifically, this dataset provides all the numbers and statistics presented under the results section and tables and figures of the publication regarding consort flow, patient enrollment, patient and clinical characteristics and survival endpoints. This dataset is presented at patient level and includes one record per patient. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®